Advanced glycation end products of bovine serum albumininduced endothelial-to-mesenchymal transition in cultured human and monkey endothelial cells via protein kinase B signaling cascades

Molecular Vision

Volumn 16, Issue , 2010, Pages 2669-2679

  Ma, Jianli ^a,b   Liu, Ting ^b   Dong, Xiaoguang ^b  

^a WEIFANG MEDICAL UNIVERSITY   (China)

^b SHANDONG EYE INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BETA CATENIN; BOVINE SERUM ALBUMIN; NERVE CELL ADHESION MOLECULE; PROTEIN KINASE B; VASCULAR ENDOTHELIAL CADHERIN; VIMENTIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL LINE; CELL MIGRATION; CELL MOTILITY; CELL TRANSFORMATION; CHOROID; CONTROLLED STUDY; ENDOTHELIAL MESENCHYMAL TRANSITION; ENDOTHELIUM CELL; HAPLORHINI; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA CELL; SIGNAL TRANSDUCTION; UMBILICAL VEIN; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; CATTLE; CELL MOVEMENT; CELL POLARITY; CELLS, CULTURED; CHOROID; ENDOTHELIAL CELLS; FLOW CYTOMETRY; GLYCOSYLATION END PRODUCTS, ADVANCED; HAPLORHINI; HUMANS; IMMUNOHISTOCHEMISTRY; MESODERM; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; RETINA; SERUM ALBUMIN, BOVINE; SIGNAL TRANSDUCTION; TIME FACTORS; UMBILICAL VEINS;

EID: 78650784685     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M, Makita Z. Advanced glycation end productinduced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J Biol Chem 2002; 277:20309-15. [PMID: 11912219]
2. Wautier JL, Schmidt AM. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 2004; 95:233-8. [PMID: 15297385]
3. Gillery P. Advanced glycation end products (AGEs), free radicals and diabetes. J Soc Biol 2001; 195:387-90. [PMID: 11938555]
4. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994; 70:138-51. [PMID: 8139257]
5. Li YM, Steffes M, Donnelly T, Liu C, Fuh H, Basgen J, Bucala R, Vlassara H. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc Natl Acad Sci USA 1996; 93:3902-7. [PMID: 8632987]
6. Stitt AW, He C, Friedman S, Scher L, Rossi P, Ong L, Founds H, Li YM, Bucala R, Vlassara H. Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol Med 1997; 3:617-27. [PMID: 9323713]
7. Hills CE, Willars GB, Brunskill NJ. Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via upregulation of retinoic acid and HGF-related signaling pathways. Mol Endocrinol 2010; 24:822-31. [PMID: 20197308]
8. Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, Thallas-Bonke V, Thomas MC, Cooper ME, Kantharidis P. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelialto- mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 2006; 17:2484-94. [PMID: 16914537]
9. Tezuka M, Koyama N, Morisaki N, Saito Y, Yoshida S, Araki N, Horiuchi S. Angiogenic effects of advanced glycation end products of the Maillard reaction on cultured human umbilical cord vein endothelial cells. Biochem Biophys Res Commun 1993; 193:674-80. [PMID: 7685599]
10. Yamagishi S, Yonekura H, Yamamoto Y, Katsuno K, Sato F, Mita I, Ooka H, Satozawa N, Kawakami T, Nomura M, Yamamoto H. Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem 1997; 272:8723-30. [PMID: 9079706]
11. Krolewski AS, Warram JH, Valsania P, Martin BC, Laffel LM, Christlieb AR. Evolving natural history of coronary artery disease in diabetes mellitus. Am J Med 1991; 90:56S-61S. [PMID: 1994719]
12. Zavadil J, Haley J, Kalluri R, Muthuswamy SK, Thompson E. Epithelial-mesenchymal transition. Cancer Res 2008; 68:9574-7. [PMID: 19047131]
13. Casaroli-Marano RP, Pagan R, Vilaró S. Epithelialmesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1999; 40:2062-72. [PMID: 10440262]
14. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7:131-42. [PMID: 16493418]
15. Liu Y. Epithelial to mesenchymal transition In renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004; 15:1-12. [PMID: 14694152]
16. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112:1776-84. [PMID: 14679171]
17. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelialmesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006; 172:973-81. [PMID: 16567498]
18. Lee YJ, Han HJ. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3{beta}, Snail1, and {beta}-catenin in renal proximal tubule cells. Am J Physiol Renal Physiol. 2009
19. Nath AK, Brown RM, Michaud M, Sierra-Honigmann MR, Snyder M, Madri JA. Leptin affects endocardial cushion formation by modulating EMT and migration via Akt signaling cascades. J Cell Biol 2008; 181:367-80. [PMID: 18411306]
20. Otero K, Martínez F, Beltrán A, González D, Herrera B, Quintero G, Delgado R, Rojas A. Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells. Biochem J 2001; 359:567-74. [PMID: 11672430]
21. Medigeshi GR, Hirsch AJ, Brien JD, Uhrlaub JL, Mason PW, Wiley C, Nikolich-Zugich J, Nelson JA. West nile virus capsid degradation of claudin proteins disrupts epithelial barrier function. J Virol 2009; 83:6125-34. [PMID: 19369347]
22. Stitt AW. The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp Mol Pathol 2003; 75:95-108. [PMID: 12834631]
23. Stitt AW, Frizzell N, Thorpe SR. Advanced glycation and advanced lipoxidation: possible role in initiation and progression of diabetic retinopathy. Curr Pharm Des 2004; 10:3349-60. [PMID: 15544520]
24. Stitt AW, Jenkins AJ, Cooper ME. Advanced glycation end products and diabetic complications. Expert Opin Investig Drugs 2002; 11:1205-23. [PMID: 12225243]
25. Yamagishi S, Hsu CC, Taniguchi M, Harada S, Yamamoto Y, Ohsawa K, Kobayashi K, Yamamoto H. Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy. Biochem Biophys Res Commun 1995; 213:681-7. [PMID: 7646524]
26. Yamagishi S, Kobayashi K, Yamamoto H. Vascular pericytes not only regulate growth, but also preserve prostacyclinproducing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells. Biochem Biophys Res Commun 1993; 190:418-25. [PMID: 8427585]
27. Navaratna D, McGuire PG, Menicucci G, Das A. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes 2007; 56:2380-7. [PMID: 17536065]
28. Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol 1997; 150:523-31. [PMID: 9033268]
29. Tan X, Dagher H, Hutton CA, Bourke JE. Effects of PPAR gamma ligands on TGF-beta1-induced epithelialmesenchymal transition in alveolar epithelial cells. Respir Res 2010; 11:21. [PMID: 20178607]
30. Pozharskaya V, Torres-González E, Rojas M, Gal A, Amin M, Dollard S, Roman J, Stecenko AA, Mora AL. Twist: a regulator of epithelial-mesenchymal transition in lung fibrosis. PLoS ONE 2009; 4:e7559. [PMID: 19851501]
31. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. Twist,a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117:927-39. [PMID: 15210113]
32. Mironchik Y, Winnard PT Jr, Vesuna F, Kato Y, Wildes F, Pathak AP, Kominsky S, Artemov D, Bhujwalla Z, Van Diest P, Burger H, Glackin C, Raman V. Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Res 2005; 65:10801-9. [PMID: 16322226]
33. Li TY, Wang SG, Li DJ, Gao ZF, Gao YH, Jiang WW. Effect of hepatitis C virus core protein on cholangiocarcinoma tissues' epithelial-mesenchymal transition. Zhonghua Wai Ke Za Zhi 2007; 45:1491-3. [PMID: 18275718]
34. Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L. VEGFreceptor signal transduction. Trends Biochem Sci 2003; 28:488-94. [PMID: 13678960]
35. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995; 376:62-6. [PMID: 7596435]
36. Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376:66-70. [PMID: 7596436]
37. Massagué J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103:295-309. [PMID: 11057902]
38. Ortega S, Ittmann M, Tsang SH, Ehrlich M, Basilico C. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci USA 1998; 95:5672-7. [PMID: 9576942]
39. Bertolino P, Deckers M, Lebrin F, ten Dijke P. Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders. Chest 2005; 128:585S-90S. [PMID: 16373850]
40. Karsan A, Yee E, Poirier GG, Zhou P, Craig R, Harlan JM. Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms. Am J Pathol 1997; 151:1775-84. [PMID: 9403728]
41. Liebner S, Cavallaro U, Dejana E. The multiple languages of endothelial cell-to-cell communication. Arterioscler Thromb Vasc Biol 2006; 26:1431-8. [PMID: 16556854]
42. Cattelino A, Liebner S, Gallini R, Zanetti A, Balconi G, Corsi A, Bianco P, Wolburg H, Moore R, Oreda B, Kemler R, Dejana E. The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility. J Cell Biol 2003; 162:1111-22. [PMID: 12975353]
43. Lampugnani MG, Orsenigo F, Gagliani MC, Tacchetti C, Dejana E. Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J Cell Biol 2006; 174:593-604. [PMID: 16893970]
44. Ukropec JA, Hollinger MK, Salva SM, Woolkalis MJ. SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J Biol Chem 2000; 275:5983-6. [PMID: 10681592]
45. Hatsell S, Rowlands T, Hiremath M, Cowin P. h-Catenin and Tcfs in mammary development and cancer. J Mammary Gland Biol Neoplasia 2003; 8:145-58. [PMID: 14635791]
46. Campbell RJ, Pignatelli M. Molecular histology in the study of solid tumours. Mol Pathol 2002; 55:80-2. [PMID: 11950953]
47. Lazarides E. Intermediate filaments as mechanical integrators of cellular space. Nature 1980; 283:249-56. [PMID: 7188712]
48. Lampugnani MG, Dejana E. Interendothelial junctions: structure, signalling and functional roles. Curr Opin Cell Biol 1997; 9:674-82. [PMID: 9330871]
49. Navarro P, Ruco L, Dejana E. Differential localization of VEand N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization. J Cell Biol 1998; 140:1475-84. [PMID: 9508779]
50. Alexander NR, Tran NL, Rekapally H, Summers CE, Glackin C, Heimark RL. N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1. Cancer Res 2006; 66:3365-9. [PMID: 16585154]
51. Qi J, Chen N, Wang J, Siu CH. Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. Mol Biol Cell 2005; 16:4386-97. [PMID: 15987741]
52. Qi J, Wang J, Romanyuk O, Siu CH. Involvement of Src family kinases in N-cadherin phosphorylation and beta-catenin dissociation during transendothelial migration of melanoma cells. Mol Biol Cell 2006; 17:1261-72. [PMID: 16371504]
53. Maeda M, Johnson KR, Wheelock MJ. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci 2005; 118:8738-87.
54. Guan F, Handa K, Hakomori SI. Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines. Proc Natl Acad Sci USA 2009; 106:7461-6. [PMID: 19380734]
55. Mullin JM. Potential interplay between luminal growth factors and increased tight junction permeability in epithelial carcinogenesis. J Exp Zool 1997; 279:484-9. [PMID: 9392870]
56. Stevenson BR, Keon BH. The tight junction: morphology to molecules. Annu Rev Cell Dev Biol 1998; 14:89-109. [PMID: 9891779]
57. Cereijido M, Ponce A, Gonzalez-Mariscal L. Tight junctions and apical/basolateral polarity. J Membr Biol 1989; 110:1-9.
58. Revenu C, Gilmour D. EMT 2.0: shaping epithelia through collective migration. Curr Opin Genet Dev 2009; 19:338-42. [PMID: 19464162]
59. Lee H, O'Meara SJ, O'Brien C, Kane R. The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 2007; 48:4291-9. [PMID: 17724219]
60. Sheikpranbabu S, Haribalaganesh R, Lee KJ, Gurunathan S. Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability. Biochimie 2010; 92:1040-51. [PMID: 20470857]
61. Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu LJ, Kong QL, Xu LH, Zhang X, Liu WL, Li MZ, Zhang L, Kang TB, Fu LW, Huang WL, Xia YF, Tsao SW, Li M, Band V, Band H, Shi QH, Zeng YX, Zeng MS. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelialmesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 2009; 119:3626-36. [PMID: 19884659]
62. Altomare DA, Testa JR. Perturbations of the AKT signaling pathway in human cancer. Oncogene 2005; 24:7455-64. [PMID: 16288292]
63. Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene 2005; 24:7443-54. [PMID: 16288291]
64. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000; 275:36803-10. [PMID: 10969078]
65. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN, Larue L. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 2003; 63:2172-8. [PMID: 12727836]
66. Julien S, Puig I, Caretti E, Bonaventure J, Nelles L, van Roy F, Dargemont C, de Herreros AG, Bellacosa A, Larue L. Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 2007; 26:7445-56. [PMID: 17563753]
67. Wang H, Quah SY, Dong JM, Manser E, Tang JP, Zeng Q. PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition. Cancer Res 2007; 67:2922-6. [PMID: 17409395]